Supernus Pharmaceuticals, Inc.
Busy Philipps Encourages Women to Take Charge of Their ADHD This Fall in Ongoing Collaboration with Supernus Pharmaceuticals and Qelbree
September 24, 2024 07:30 ET | Supernus Pharmaceuticals, Inc.
Ahead of ADHD Awareness Month, Busy is sharing her ADHD diagnosis and Qelbree® (viloxazine extended-release capsules) treatment story to empower women living with ADHD to advocate for their care.ADHD...
edited logo.jpg
Draganfly Receives Military Purchase Order for its Commander 3XL to be used for logistics within various branches of the U.S. Department of Defense
September 24, 2024 07:30 ET | Draganfly Inc
Commander 3XL to be used as a primary transport vehicle for the TB2 Aerospace DROPS UAV Cargo POD for autonomous tactical resupply Saskatoon Sask, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc....
Logo Resized for Globe Newswire2.jpg
Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
September 24, 2024 07:30 ET | Wave Life Sciences USA, Inc.
Mean muscle content-adjusted dystrophin expression of 9.0% and unadjusted dystrophin of 5.5%, with high consistency across participants, in a prespecified analysis; dystrophin was comprised of two...
zevra_inline_fullcolor_rgb_12in@300ppi (1).png
Zevra Therapeutics to Present Top-Line Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia at Sleep Europe 2024
September 24, 2024 07:30 ET | Zevra Therapeutics
KP1077 demonstrates clinically meaningful benefits for key IH symptoms Top-line data provide key information for the design of a Phase 3 study CELEBRATION, Fla., Sept. 24, 2024 ...
Cytokinetics.png
Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program
September 24, 2024 07:30 ET | Cytokinetics, Incorporated
Program to Provide $100,000 in Support of Communications and Outreach for Patient Advocacy Organizations Focused on Cardiovascular Diseases Deadline for Applications is November 4th, 2024 SOUTH SAN...
Repligen_Logo-HORIZONTAL-withtagline (1).jpg
Repligen Opens Training & Innovation Center to Elevate Customer Experience
September 24, 2024 07:30 ET | Repligen Corporation
Repligen opens Training and Innovation Center (RTIC) to support biopharma and CDMO customer experience with the company's bioprocessing technologies.
Hookipa Pharma Logo Square.png
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
September 24, 2024 07:30 ET | HOOKIPA Pharma Inc.
NEW YORK and VIENNA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK) (“HOOKIPA” or the “Company”), a clinical-stage biopharmaceutical company developing next generation...
NCino Logo.png
BankNewport Reports Deposit Account Opening Process Accelerated by as much as Ninety Percent, Streamlining a Key Consumer Banking Experience with nCino
September 24, 2024 07:30 ET | nCino, Inc.
WILMINGTON, N.C., Sept. 24, 2024 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced that BankNewport is live on the...
ocugen_4C_LOGO (002).png
Ocugen to Participate in a Fireside Chat at Chardan’s 8th Annual Genetic Medicines Conference
September 24, 2024 07:30 ET | Ocugen
MALVERN, Pa., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
factMR-logo.png
Railway Sleeper Market is Anticipating a 5.7% CAGR Growth, Reaching a Valuation of US$ 21.33 Billion by 2034 | Fact.MR Report
September 24, 2024 07:30 ET | FACT.MR
Rockville, MD, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Latest projections by Fact.MR are that the global railway sleeper market will reach a value of US$ 12.25 billion in 2024 and is projected to expand...